Clinical Trial Update: A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Clinical Trial Evaluating the Safety of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease [Phase 3]

View source ↗

Summary

Phase 3, multicenter, double-masked trial evaluating safety of Reproxalap ophthalmic solution in Dry Eye Disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Reproxalap (reproxalap)

Snippet

Sponsor: Aldeyra Therapeutics, Inc. | Conditions: Dry Eye Disease | Phase 3 | Status: COMPLETED | Results posted: 2025-11-26